|
|
|
|
LEADER |
00000nam a22000005i 4500 |
001 |
978-1-4614-4741-2 |
003 |
DE-He213 |
005 |
20220118231103.0 |
007 |
cr nn 008mamaa |
008 |
121206s2013 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781461447412
|9 978-1-4614-4741-2
|
024 |
7 |
|
|a 10.1007/978-1-4614-4741-2
|2 doi
|
050 |
|
4 |
|a RC261-271
|
072 |
|
7 |
|a MJCL
|2 bicssc
|
072 |
|
7 |
|a MED062000
|2 bisacsh
|
072 |
|
7 |
|a MJCL
|2 thema
|
082 |
0 |
4 |
|a 571.978
|2 23
|
082 |
0 |
4 |
|a 616.994
|2 23
|
245 |
1 |
0 |
|a Advances in DNA Repair in Cancer Therapy
|h [electronic resource] /
|c edited by Lawrence Panasci, Raquel Aloyz, Moulay Alaoui-Jamali.
|
250 |
|
|
|a 1st ed. 2013.
|
264 |
|
1 |
|a New York, NY :
|b Springer New York :
|b Imprint: Humana,
|c 2013.
|
300 |
|
|
|a VIII, 312 p.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Cancer Drug Discovery and Development,
|x 2196-9914
|
505 |
0 |
|
|a Preface -- Repair of DNA Interstrand Cross-links Produced by Cancer Chemotherapeutic Drugs -- DNA-PK, a pharmacological target in cancer chemotherapy and radiotherapy? -- Growth factor receptor signaling, DNA damage response, and cancer cell susceptibility to chemotherapy and relapses -- The relationship between DNA-repair genes, cellular radiosensitivity and the response of tumors and normal tissues to radiotherapy -- Important Roles of ERCC1 in DNA Repair and Targeted Therapy -- The role of BRCA1 and BRCA2 in anticancer drug therapy -- DNA-PK in CLL Chemotherapy -- Poly(ADP) ribose polymerase at the interface of DNA damage signalling and DNA repair -- Cellular protection against the antitumor drug bleomycin -- ATR as a Therapeutic Target -- Telomeres, Telomerase and DNA Damage Response in Cancer Therapy -- RAD51 is a key protein of DNA repair and homologous recombination in humans -- Index.
|
520 |
|
|
|a This book deals with the emerging role of various DNA repair proteins and the regulatory elements which are implicated in cancer therapy such as DNA cross-linking agents, radiotherapy and bleomycin. The DNA repair genes discussed include those involved in BRCA/Rad51-related homologous recombinational repair, DNA-PK related nonhomologous endjoining and the nucleotide excision repair gene, ERCC1. Moreover, the role of regulatory genes such as PARP, ATR, telomerase, growth factor receptors and downstream kinase signalling is examined.
|
650 |
|
0 |
|a Cancer.
|
650 |
|
0 |
|a Medicine-Research.
|
650 |
|
0 |
|a Biology-Research.
|
650 |
1 |
4 |
|a Cancer Biology.
|
650 |
2 |
4 |
|a Biomedical Research.
|
700 |
1 |
|
|a Panasci, Lawrence.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
700 |
1 |
|
|a Aloyz, Raquel.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
700 |
1 |
|
|a Alaoui-Jamali, Moulay.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer Nature eBook
|
776 |
0 |
8 |
|i Printed edition:
|z 9781461447405
|
776 |
0 |
8 |
|i Printed edition:
|z 9781461447429
|
776 |
0 |
8 |
|i Printed edition:
|z 9781489993083
|
830 |
|
0 |
|a Cancer Drug Discovery and Development,
|x 2196-9914
|
856 |
4 |
0 |
|u https://doi.uam.elogim.com/10.1007/978-1-4614-4741-2
|z Texto Completo
|
912 |
|
|
|a ZDB-2-SME
|
912 |
|
|
|a ZDB-2-SXM
|
950 |
|
|
|a Medicine (SpringerNature-11650)
|
950 |
|
|
|a Medicine (R0) (SpringerNature-43714)
|